Overview

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Status:
Completed
Trial end date:
2016-11-17
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety of Rosuvastatin in Children and Adolescents with Homozygous Familial Hypercholesterolemia.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium